Visitors Now:
Total Visits:
Total Stories:
Profile image
By Hispanically Speaking News (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Study Finds Mammograms Can Measure How Breast Cancer Drug Is Working

Wednesday, April 24, 2013 7:16
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Study Finds Mammograms Can Measure How Breast Cancer Drug Is Working

Those on tamoxifen who showed reduction in breast density had 50 percent lower risk of death within 15 years.

Mammograms can be used to see how well breast cancer patients are responding to treatment with the drug tamoxifen, a new study suggests.

Researchers at the Karolinska Institute in Sweden report that women who saw a 20 percent or more reduction in breast density during tamoxifen treatment had a 50 percent lower risk of dying from breast cancer over an average of 15 years, compared with women who had little or no change in breast tissue density during treatment.

The study uncovered a link between reductions in breast density while on tamoxifen and a lowered risk of death. However, it didn’t find a cause-and-effect relationship.

Using mammograms to determine if a patient is responding to tamoxifen can be done at an early stage of treatment, the researchers added.

The Swedish team looked at nearly 1,000 postmenopausal women who had been treated for breast cancer. About half of them had been treated with tamoxifen, according to the study, which was published online April 22 in the Journal of Clinical Oncology.

Tamoxifen is a common hormone-therapy drug typically given over five years to prevent relapse in women who have completed their primary breast cancer treatment. However, there has been no way to assess which patients are most likely to respond to tamoxifen treatment.

These findings suggest a possible method for doing so, the researchers said.

“What’s needed is accurate measurement of mammographic density, which isn’t currently routine,” Per Hall, a professor in the department of medical epidemiology and biostatistics, said in a Karolinska Institute news release. “Measuring changes in density can be a simple and cheap means of assessing the effect of the treatment. If a patient is not responding to tamoxifen, maybe they should be given a different drug.”

More information

The U.S. National Cancer Institute has more about breast cancer treatment.

Published in Hispanic Health News



Source:

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.